Shareholder plans sale of 7,242 shares

Christopher Cline filed notice of a planned sale of 7,242 shares of common stock of TVTX, with an aggregate market value of $232,616.03.

Accepted by SEC EDGAR 02/03/2026 - 09:45 PM EST Learn about SEC filing dates

Rhea-AI Filing Summary

Christopher Cline filed notice of a planned sale of 7,242 shares of common stock of TVTX, with an aggregate market value of $232,616.03. The shares are to be sold on February 3, 2026 on the NASDAQ through Morgan Stanley Smith Barney.

The 7,242 shares were acquired on January 31, 2026 through restricted stock unit vesting from the issuer as compensation. Over the prior three months, Cline sold 20,000 common shares on December 1, 2025, generating $700,202.00 in gross proceeds.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does the Form 144 filing for TVTX disclose?

The Form 144 filing discloses that Christopher Cline plans to sell 7,242 TVTX common shares. These shares, valued at $232,616.03, will be sold on NASDAQ through Morgan Stanley Smith Barney, following their acquisition via restricted stock unit vesting on January 31, 2026.

How many TVTX shares is Christopher Cline planning to sell under this notice?

Christopher Cline plans to sell 7,242 TVTX common shares. The filing lists an aggregate market value of $232,616.03 for these shares, to be sold on NASDAQ on or about February 3, 2026, using Morgan Stanley Smith Barney as the broker.

How did Christopher Cline acquire the 7,242 TVTX shares being sold?

The 7,242 TVTX shares come from restricted stock units that vested on January 31, 2026. The filing states the shares were acquired from the issuer as compensation, with the payment date matching the vesting date, indicating they were granted as part of an equity award.

What prior TVTX share sales by Christopher Cline are disclosed?

The filing reports that Christopher Cline sold 20,000 TVTX common shares on December 1, 2025. These sales generated gross proceeds of $700,202.00, and are disclosed as securities sold during the past three months for aggregation under Rule 144 requirements.

Which broker and exchange are involved in the planned TVTX share sale?

The planned sale will be executed through Morgan Stanley Smith Barney, located in Alpharetta, Georgia. The Form 144 indicates that the 7,242 TVTX common shares are expected to be sold on the NASDAQ exchange on or about February 3, 2026.

What representation does the seller make in the TVTX Form 144 notice?

By signing the notice, the seller represents that they do not know any material adverse, nonpublic information about TVTX. The representation also applies as of any Rule 10b5-1 trading plan adoption date, if such a plan or trading instructions have been used.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001943192
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	Travere Therapeutics, Inc.
SEC File Number	001-36257
Address of Issuer	3611 Valley Centre Dr. Suite 300 San Diego CALIFORNIA 92130
Phone	888-969-7879
Name of Person for Whose Account the Securities are To Be Sold	Christopher Cline
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney 3 Edison Drive Alpharetta GA 30005	7242	232616.03	89472327	02/03/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	01/31/2026	Restricted Stock Unit Vesting	Issuer			7242	01/31/2026	Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Christopher Cline 3611 Valley Centre Drive Suite 300 San Diego CA 92130	Common	12/01/2025	20000	700202.00

144: Remarks and Signature

Remarks	Represents the number of shares required to be sold by the Reporting Person to cover the tax withholding obligation in connection with the settlement of vested restricted stock units. This sale is mandated by the Issuer's election under its equity incentive plans to require the Reporting Person to fund this tax withholding obligation by completing a "sell to cover" transaction with a brokerage firm designated by the Issuer. This sale does not represent a discretionary trade by the Reporting Person.
Date of Notice	02/03/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Elizabeth E. Reed as attorney-in-fact for Christopher Cline
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)